Omeros Corporation (OMER) Financials

OMER Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 493.1 million 507.0 million
2023-06-30 527.4 million 506.9 million
2023-03-31 560.1 million 505.2 million
2022-12-31 591.0 million 505.3 million

OMER Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -32.7 million 3.2 million
2023-06-30 -32.6 million 2.8 million
2023-03-31 174.5 million 3.0 million
2022-12-31 -25.4 million 3.3 million

OMER Net Income

No data available :(

OMER Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 310.3 million - 24.1 million
2023-06-30 341.3 million 221.5 million 25.1 million
2023-03-31 371.4 million 221.2 million 25.7 million
2022-12-31 194.9 million 220.9 million 26.7 million

OMER Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 62.9 million
2023-06-30 62.8 million
2023-03-31 62.8 million
2022-12-31 62.8 million

OMER Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 33000 31.7 million 16.4 million -
2023-06-30 275000 29.6 million 11.3 million -
2023-03-31 275000 24.6 million 11.1 million -
2022-12-31 13000 26.6 million 13.6 million -

OMER Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 197000
2023-06-30 - 300000
2023-03-31 - 186000
2022-12-31 - 163000

OMER

Price: $3.73

52 week price:
0.92
7.80

Earnings Per Share: -2.89 USD

P/E Ratio: -1.32

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 328300

Ebitda: -4.6 million

Market Capitalization: 198.0 million

Links: